175 related articles for article (PubMed ID: 15049901)
1. Cyclooxygenase-2 expression and relationship to tumour progression in human renal cell carcinoma.
Hashimoto Y; Kondo Y; Kimura G; Matsuzawa I; Sato S; Ishizaki M; Imura N; Akimoto M; Hara S
Histopathology; 2004 Apr; 44(4):353-9. PubMed ID: 15049901
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas.
Hemmerlein B; Galuschka L; Putzer N; Zischkau S; Heuser M
Histopathology; 2004 Dec; 45(6):603-11. PubMed ID: 15569051
[TBL] [Abstract][Full Text] [Related]
3. Study of cyclooxygenase-2 in renal cell carcinoma.
Yoshimura R; Matsuyama M; Kawahito Y; Tsuchida K; Kuratsukuri K; Takemoto Y; Mitsuhashi M; Sano H; Nakatani T
Int J Mol Med; 2004 Feb; 13(2):229-33. PubMed ID: 14719128
[TBL] [Abstract][Full Text] [Related]
4. [Expression of cyclooxygenase in bladder transitional cell carcinoma].
Wang KJ; Li H; Wei Q; Yang YR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):54-6. PubMed ID: 14981815
[TBL] [Abstract][Full Text] [Related]
5. Significance of COX-2 expression in human renal cell carcinoma.
Tuna B; Yorukoglu K; Gurel D; Mungan U; Kirkali Z
Urology; 2004 Dec; 64(6):1116-20. PubMed ID: 15596182
[TBL] [Abstract][Full Text] [Related]
6. Prognostic evaluation of COX-2 expression in renal cell carcinoma.
Kankuri-Tammilehto MK; Söderström KO; Pelliniemi TT; Vahlberg T; Pyrhönen SO; Salminen EK
Anticancer Res; 2010 Jul; 30(7):3023-30. PubMed ID: 20683050
[TBL] [Abstract][Full Text] [Related]
7. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].
Zhan J; Tang XD
Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218
[TBL] [Abstract][Full Text] [Related]
8. Maximal COX-2 immunostaining and clinical response to celecoxib and interferon alpha therapy in metastatic renal cell carcinoma.
Rini BI; Weinberg V; Dunlap S; Elchinoff A; Yu N; Bok R; Simko J; Small EJ
Cancer; 2006 Feb; 106(3):566-75. PubMed ID: 16369983
[TBL] [Abstract][Full Text] [Related]
9. Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival.
Miyata Y; Koga S; Kanda S; Nishikido M; Hayashi T; Kanetake H
Clin Cancer Res; 2003 May; 9(5):1741-9. PubMed ID: 12738729
[TBL] [Abstract][Full Text] [Related]
10. [Expression of IGF-IR and COX-2 in renal cell carcinoma and their relationship with cell proliferation].
Sun H; Wang H; Qin WJ; Yang B; Wang SC; Jian BL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Apr; 25(4):348-50. PubMed ID: 19351509
[TBL] [Abstract][Full Text] [Related]
11. Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma.
Hastürk S; Kemp B; Kalapurakal SK; Kurie JM; Hong WK; Lee JS
Cancer; 2002 Feb; 94(4):1023-31. PubMed ID: 11920472
[TBL] [Abstract][Full Text] [Related]
12. Expression of COX-2 in normal and pyelonephritic kidney, renal intraepithelial neoplasia, and renal cell carcinoma.
Mungan MU; Gurel D; Canda AE; Tuna B; Yorukoglu K; Kirkali Z
Eur Urol; 2006 Jul; 50(1):92-7; discussion 97. PubMed ID: 16426736
[TBL] [Abstract][Full Text] [Related]
13. Significance of Fas expression alteration during tumor progression of renal cell carcinoma.
Sejima T; Miyagawa I
Int J Urol; 2006 Mar; 13(3):257-64. PubMed ID: 16643620
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of peritumoral regulatory T cells and its correlation with intratumoral cyclooxygenase-2 expression in clear cell renal cell carcinoma.
Li JF; Chu YW; Wang GM; Zhu TY; Rong RM; Hou J; Xu M
BJU Int; 2009 Feb; 103(3):399-405. PubMed ID: 19021626
[TBL] [Abstract][Full Text] [Related]
15. Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium.
Wang W; Bergh A; Damber JE
Prostate; 2004 Sep; 61(1):60-72. PubMed ID: 15287094
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
Mizutani Y; Nakanishi H; Yamamoto K; Li YN; Matsubara H; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
J Clin Oncol; 2005 Jan; 23(3):448-54. PubMed ID: 15572731
[TBL] [Abstract][Full Text] [Related]
17. Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesions.
Ferrandina G; Ranelletti FO; Salutari V; Gessi M; Legge F; Zannoni GF; Scambia G; Lauriola L
Gynecol Oncol; 2004 Feb; 92(2):537-44. PubMed ID: 14766245
[TBL] [Abstract][Full Text] [Related]
18. Expression of cyclooxygenase-2 in canine renal cell carcinoma.
Khan KN; Stanfield KM; Trajkovic D; Knapp DW
Vet Pathol; 2001 Jan; 38(1):116-9. PubMed ID: 11199159
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 expression in human thyroid carcinoma and Hashimoto's thyroiditis.
Cornetta AJ; Russell JP; Cunnane M; Keane WM; Rothstein JL
Laryngoscope; 2002 Feb; 112(2):238-42. PubMed ID: 11889377
[TBL] [Abstract][Full Text] [Related]
20. Down-regulated expression of RhoA in human conventional renal cell carcinoma.
Pu YS; Wang CW; Liu GY; Kuo YZ; Huang CY; Kang WY; Shun CT; Lin CC; Wu WJ; Hour TC
Anticancer Res; 2008; 28(4B):2039-43. PubMed ID: 18751372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]